Researchers analyzed 18 studies where participants learned their risk of diseases that could be lowered by behavioral changes, such as smoking cessation, diet, alcohol use and physical activity.
They found communicating this DNA-based risk to participants was not effective in changing individuals’ health-related behavior.
“Existing evidence does not support expectations that such interventions could play a major role in motivating behavior change to improve population health,” the researchers concluded.
More articles on personalized medicine:
Precision medicine market set to reach $88B by 2022: 4 things to know
What advances in genomic research mean for federal health IT
6 vendors opening data access for Precision Medicine Initiative
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
